Neurothrombectomy Devices Market Share

Statistics for the 2023 & 2024 Neurothrombectomy Devices market share, created by Mordor Intelligence™ Industry Reports. Neurothrombectomy Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Neurothrombectomy Devices Industry

The neurothrombectomy devices market is highly competitive in nature, with many key players dominating the market. The presence of major market players, such as Abbott Laboratories, Johnson & Johnson, Medtronic, Stryker, and Vesalio, is intensifying the competition. The market players are adopting strategies, such as R&D, mergers, acquisitions, and product innovations, to sustain the increasing market rivalry.

In April 2019, Medtronic launched its fourth-generation Solitaire X revascularization device for AIS treatment.

Neurothrombectomy Devices Market Leaders

  1. Medtronic

  2. Stryker

  3. Siemens Healthineers

  4. Acandis

  5. INARI Medical

*Disclaimer: Major Players sorted in no particular order

Medtronic, Stryker, Siemens Healthineers, Acandis, INARI Medical

Neurothrombectomy Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)